United Therapeutics (UTHR) Return on Equity [ROE] (2009 - 2026)
United Therapeutics' Return on Equity [ROE] was 21.31% in Q2 2026, up 3.54 percentage points from 17.77% a year earlier and up 1.50 percentage points from the prior quarter.
Powered by 
Analysis
United Therapeutics (UTHR) Return on Equity [ROE] (2009 - 2026) Analysis & Trends
For FY2025, Return on Equity [ROE] at United Therapeutics came in at 19.71%, up 0.48 percentage points from FY2024.
- Return on Equity [ROE] has now increased for four consecutive years, with a five-year change of +3.04 percentage points (FY2020 to FY2025).
- In earlier years, Return on Equity [ROE] was 19.23% in FY2024 (+0.96 pp), 18.27% in FY2023 (+1.65 pp), 16.61% in FY2022 (+3.67 pp) and 12.94% in FY2021 (-3.73 pp).
- The Q2 2026 figure marks the highest quarterly Return on Equity [ROE] since Q4 2018.
- Compared with a year earlier, Return on Equity [ROE] has increased for three straight quarters, with an average year-over-year change of +1.02 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Equity [ROE] over five years was Q1 2022 (a gain of 5.05 percentage points); the worst was Q4 2021 (a drop of 3.20 percentage points).
- Per Business Quant data, UTHR's Return on Equity [ROE] in the three quarters before Q2 2026 was 19.81% (Q1 2026), 19.50% (Q4 2025) and 18.48% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | United Therapeutics | 24.95 Bn | 15.14 Bn | 733.40 Mn | 19.42% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 19.42% |
| Jun 30, 2026 | 21.31% |
| Mar 31, 2026 | 19.81% |
| Dec 31, 2025 | 19.50% |
| Sep 30, 2025 | 18.48% |
| Jun 30, 2025 | 17.77% |
| Mar 31, 2025 | 18.27% |
| Dec 31, 2024 | 19.05% |
| Sep 30, 2024 | 18.83% |
| Jun 30, 2024 | 19.38% |
| Mar 31, 2024 | 18.56% |
| Dec 31, 2023 | 16.84% |
| Sep 30, 2023 | 16.18% |
| Jun 30, 2023 | 16.55% |
| Mar 31, 2023 | 14.68% |
| Dec 31, 2022 | 15.54% |
| Sep 30, 2022 | 15.93% |
| Jun 30, 2022 | 14.85% |
| Mar 31, 2022 | 16.90% |
| Dec 31, 2021 | 12.22% |
API Access
United Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=UTHR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "UTHR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=UTHR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();